Works by Ghahremanzadeh, Neda


Results: 3
    1

    Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.

    Published in:
    Vaccines, 2023, v. 11, n. 2, p. 455, doi. 10.3390/vaccines11020455
    By:
    • Dodaran, Masoud Solaymani;
    • Banihashemi, Seyed Reza;
    • Es-haghi, Ali;
    • Mehrabadi, Mohammad Hossein Fallah;
    • Nofeli, Mojtaba;
    • Mokarram, Ali Rezaei;
    • Mokhberalsafa, Ladan;
    • Sadeghi, Fariba;
    • Ranjbar, Alireza;
    • Ansarifar, Akram;
    • Mohazzab, Arash;
    • Setarehdan, Seyed Amin;
    • Bagheri Amiri, Fahimeh;
    • Mohseni, Vahideh;
    • Hajimoradi, Monireh;
    • Ghahremanzadeh, Neda;
    • Razzaz, Seyed Hossein;
    • Masoomi, Safdar;
    • Taghdiri, Maryam;
    • Bagheri, Mohsen
    Publication type:
    Article
    2
    3